IVUS technology enables physicians to obtain high-resolution, cross-sectional images of blood vessels and surrounding tissues from inside the vascular system. The technology is increasingly important in complex coronary procedures, where conventional angiography may not provide sufficient visualization for treatment planning and optimization.

Growing Role of IVUS in Coronary Intervention

Coronary intervention represents one of the most important application areas for IVUS devices. The technology enables clinicians to evaluate vessel dimensions, plaque characteristics, lesion morphology, stent positioning, and treatment outcomes with greater precision.

IVUS-guided coronary interventions can help physicians make more informed procedural decisions and optimize stent deployment. The increasing emphasis on reducing major adverse cardiovascular events and improving procedural outcomes is consequently supporting adoption across cardiovascular care settings.

The growing complexity of coronary artery disease is also creating opportunities for advanced intravascular imaging. Chronic total occlusion (CTO) lesions, for example, can present substantial challenges during revascularization. IVUS imaging can help clinicians distinguish the true vascular lumen from the subintimal space and identify anatomical features such as side branches, intima, and media.

This capability can support guidewire navigation and confirmation of guidewire re-entry into the true lumen, making IVUS an increasingly valuable tool when conventional wiring approaches are unsuccessful.

IVUS Catheters Support Precision Treatment Planning

IVUS catheters are emerging as a critical component of the technology ecosystem because they provide physicians with real-time visualization during minimally invasive vascular procedures. Advanced catheters can support both coronary and peripheral applications and help clinicians determine appropriate treatment strategies for individual patients.

Pre-stent planning is another important area of application. Detailed visualization of vessel anatomy can assist physicians in determining appropriate stent dimensions and positioning while supporting assessment after implantation.

The expanding use of catheter-based cardiovascular procedures is therefore expected to create sustained demand for specialized IVUS catheters. Manufacturers are focusing on catheter design, transducer performance, imaging resolution, and ease of integration with existing clinical workflows to strengthen product capabilities.

Hybrid IVUS-OCT Technologies Open New Possibilities

Technological convergence is becoming an important trend in the intravascular imaging landscape. Medical technology companies are increasing research and development efforts involving IVUS and optical coherence tomography (OCT) to improve visualization of intracoronary structures.

Although both technologies offer distinct imaging advantages, their effectiveness can vary depending on anatomical conditions and patient characteristics. Hybrid approaches could potentially provide physicians with complementary information and improve decision-making in complex coronary disease.

The development of combined IVUS-OCT catheter technologies is particularly relevant for patients with multi-vessel coronary artery disease, where comprehensive visualization can support diagnosis and treatment planning.

Innovation in Ultrasound Transducers

Advances in ultrasound transducer technology are expected to play a major role in the evolution of IVUS devices. Transducers act as both transmitters and detectors, sending acoustic waves and receiving returning signals to generate detailed images of vascular structures.

Traditional piezoelectric transducers remain important in biomedical imaging, but manufacturers face challenges associated with fabricating high-density arrays. These limitations are encouraging companies and research organizations to investigate alternative approaches, including microelectromechanical systems (MEMS)-based micromachined ultrasound transducers.

MEMS technology offers potential advantages in terms of integration and miniaturization. Its compatibility with complementary metal-oxide-semiconductor (CMOS) technologies could support development of compact and sophisticated imaging systems.

Further innovation in this area could contribute to faster imaging, improved image quality, reduced motion artifacts, and enhanced visualization during cardiovascular procedures.

Specialty Clinics and Hospitals Drive Adoption

Hospitals remain central to the adoption of IVUS systems because of their role in performing complex cardiovascular interventions and maintaining advanced diagnostic infrastructure. At the same time, specialty clinics are expected to represent an increasingly attractive growth area.

The specialty clinics segment is projected to expand at a high CAGR during the forecast period. Capacity-building initiatives and increasing adoption of advanced cardiovascular imaging systems are expected to contribute to this trend.

Ambulatory surgical centers, diagnostic laboratories, and research institutes also represent important end-user categories. As minimally invasive procedures become increasingly integrated into cardiovascular treatment pathways, demand for compact and efficient imaging systems could expand beyond conventional hospital environments.

Disinfection and Infection-Control Practices Remain Important

The COVID-19 pandemic highlighted the importance of infection-control protocols for ultrasound and catheter-based imaging equipment. IVUS procedures involve interaction among patients, physicians, imaging systems, and associated equipment, making appropriate cleaning and disinfection practices an important consideration.

Healthcare facilities have increased attention toward systematic sanitization procedures and the appropriate use of disinfectants for compatible components. Manufacturers and healthcare providers are expected to continue emphasizing device handling, cleaning, and infection-control practices as part of safe clinical operations.

Competitive Landscape and Industry Innovation

The competitive environment includes established medical-device manufacturers and specialized imaging technology companies. Major participants identified in the IVUS devices market include Axle International, Boston Scientific Corporation, Infraredx, Koninklijke Philips N.V., Terumo Corporation, Siemens Healthineers AG, Conavi Medical Inc., and ACIST Medical Systems.

Competition is centered on imaging performance, catheter design, product portfolios, clinical usability, technological innovation, and the ability to support coronary as well as peripheral vascular applications.

Manufacturers are increasingly focused on R&D and product development to deliver higher-resolution imaging, improved catheter maneuverability, and more efficient integration with cardiovascular intervention workflows.

Outlook

The outlook for the global intravascular ultrasound devices market remains positive as healthcare systems place greater emphasis on precision diagnosis, minimally invasive cardiovascular procedures, and improved treatment outcomes. Rising cardiovascular disease prevalence and an aging population are expected to sustain underlying demand, while technological advances could broaden the clinical applications of IVUS.

Over the coming years, the combination of advanced IVUS catheters, hybrid IVUS-OCT systems, MEMS-based transducers, and improved imaging platforms is likely to shape the competitive landscape. As physicians increasingly seek detailed anatomical information before, during, and after vascular interventions, IVUS is positioned to become an increasingly important component of image-guided cardiovascular care.

With the market projected to surpass US$1.22 billion by 2031 and grow at approximately 7.1% CAGR, continued investment in imaging technology, catheter innovation, clinical research, and healthcare infrastructure is expected to create new opportunities for manufacturers across major regional markets.